Response: Comments on "Role of 5-aminosalicylic acid in ulcerative colitis management in 8 Asian territories: a physician survey" [0.03%]
关于“5氨基水杨酸在8个亚洲地区溃疡性结肠炎管理中的作用：一项针对医师的调查”的评论
Julajak Limsrivilai,Wai Keung Leung
Julajak Limsrivilai
Comments on "Role of 5-aminosalicylic acid in ulcerative colitis management in 8 Asian territories: a physician survey" [0.03%]
关于“水杨酸氨乙磺酸在八大亚洲地区溃疡性结肠炎管理中的作用：一项对医生的调查”的评论
Tsutomu Nishida,Takahiro Amano,Naoto Osugi et al.
Tsutomu Nishida et al.
Elevated IL-6 levels in the intestinal mucosa of patients with gastrointestinal Behçet's disease [0.03%]
肠道黏膜中IL-6水平升高与胃肠道贝赫切特病有关
Jihye Park,Arjun Ravi,Katharina Bruzelius et al.
Jihye Park et al.
The impact of the quality improvement program on Clostridioides difficile infection management: a quasi-experimental study [0.03%]
一项关于质控计划对艰难梭菌感染管理影响的准实验研究
Jung Yun Lee,Jae-Ki Choi,Tae-Geun Gweon et al.
Jung Yun Lee et al.
Background/aims: Clostridioides difficile infection (CDI) is a major cause of nosocomial diarrhea. This study aimed to implement a quality improvement program to expedite proper CDI treatment, including discontinuing laxa...
Knowledge and acceptability of the Lémann Index as a tool to measure disease progression and bowel damage in Crohn's disease: results from an international survey [0.03%]
Lémann指数用于测量克罗恩病病情进展和肠道损害的知识及可接受性：一项国际调查的结果
Charlotte Wong,Johan Burisch,Ryan C Ungaro et al.
Charlotte Wong et al.
Background/aims: Crohn's disease (CD) progresses to structural bowel damage (SBD). The Lémann Index (LI) captures stricture extent/severity, penetrating disease and surgery as a SBD score, and is earmarked for future CD ...
Practices and perceptions of 5-aminosalicylic acid use in Crohn's disease: a nationwide survey of physicians in Korea by KASID Guidelines Taskforce Team [0.03%]
韩国克罗恩病5-氨基水杨酸使用实践及认知的全国医师调查(KASID指南工作组)
June Hwa Bae,Seung Yong Shin,Dong Hyun Kim et al.
June Hwa Bae et al.
Background/aims: Despite international guidelines recommending against the use of 5-aminosalicylic acid (5-ASA) for Crohn's disease (CD), it remains widely prescribed. This study aimed to investigate current patterns of 5...
Elderly-onset inflammatory bowel disease in Asia: clinical characteristics and therapeutic strategies [0.03%]
亚洲老年人群炎症性肠病的临床特点和治疗策略
Jiyoung Yoon,Daein Kim,You Sun Kim
Jiyoung Yoon
The incidence and prevalence of elderly-onset inflammatory bowel disease (EO-IBD) are increasing worldwide. The rising incidence of EO-IBD in Asia is driven by rapid industrialization and an aging population. Older patients often have multi...
Asian-Pacific perspectives on the management of very early-onset inflammatory bowel disease [0.03%]
亚太地区关于极早发炎症性肠病管理的观点
Ichiro Takeuchi,Katsuhiro Arai,Pornthep Tanpowpong et al.
Ichiro Takeuchi et al.
Children diagnosed with inflammatory bowel disease (IBD) before the age of 6 years are considered to have "very early-onset IBD (VEO-IBD)," which is challenging to diagnose and treat. Notably, many children with VEO-IBD have monogenic forms...
Targeting the gut microbiome in inflammatory bowel disease: from concept to clinical reality [0.03%]
从概念到临床现实：靶向肠道微生物群治疗炎症性肠病
Nathalie Rolhion,Harry Sokol
Nathalie Rolhion
The gut microbiota, a complex community of trillions of microorganisms inhabiting the human gastrointestinal tract, has emerged as a critical regulator of immune homeostasis and gastrointestinal health. In the context of inflammatory bowel ...
Three Janus kinase inhibitors in ulcerative colitis: is upadacitinib taking the lead? [0.03%]
溃疡性结肠炎的三种Janus激酶抑制剂：Upadacitinib能否领先？
Yoon Suk Jung
Yoon Suk Jung